Abbott | ABT - Market Capitalization


Abbott reported $190.08B in Market Capitalization this November of 2026, considering the latest stock price and the number of outstanding shares.





Market Capitalization Change Date
Abbott USD 171.01B 12.96B Sep/2026
Agilent USD 39.08B 6.43B Jun/2026
AtriCure USD 2.95B 90M Nov/2026
Baxter International USD 12.41B 1.4B Sep/2026
Becton, Dickinson and Co. USD 61.93B 13.17B Nov/2026
Bio-Rad Laboratories USD 8.71B 840M Nov/2026
Boston Scientific USD 63.6B 337M Nov/2026
Cooper Companies USD 14.1B 1.83B Jun/2026
Danaher USD 157.81B 18.96B Sep/2026
Dexcom USD 32.56B 6.57B Sep/2026
Edwards Lifesciences USD 58.61B 8.86B Nov/2026
Globus Medical USD 11.02B 969M Nov/2026
Insulet USD 11.54B 2.49B Nov/2026
Integra LifeSciences USD 1.27B 131M Sep/2026
Intuitive Surgical USD 143.65B 2.81B Sep/2026
J&J USD 653.61B 42.25B Sep/2026
Medtronic USD 109.3B 2.33B Jun/2026
Merit Medical Systems USD 5.15B 1.01B Sep/2026
Pfizer USD 165.12B 1.71B Nov/2026
Smith & Nephew USD 12.7B 621.83M Jun/2026
Stryker USD 105.63B 15.07B Sep/2026
Tandem Diabetes Care USD 1.18B 46M Nov/2026
Teleflex USD 7.16B 1.86B Nov/2026
Terumo JPY 3.31T 186.55B Jun/2026
Thermo Fisher Scientific USD 249.58B 58.93B Sep/2026
WK Kellogg Co USD 15.49B 489.38M Nov/2026
Zimmer Biomet Holdings USD 22.63B 5.69B Nov/2026